Target intelligence / Profile preview

Immunoglobulin gamma 1 Fc region (IgG1 Fc) (IgG1 Fc)

Target
IgG1 Fc
Molecular classification
Immunoglobulin, Glycoprotein, Effector molecule
01

Overview

The Immunoglobulin gamma 1 (IgG1) Fc region is the C-terminal portion of the IgG1 antibody, consisting of the CH2 and CH3 constant domains (Vidarsson G, et al. Front Immunol. 2014). It serves as the primary interface between the adaptive immune system and innate effector mechanisms by binding to Fc gamma receptors (FcγRs) on leukocytes (Wang TT, et al. Annu Rev Immunol. 2019). This interaction facilitates antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis, which are essential for clearing pathogens and tumor cells. Furthermore, the Fc region binds to the neonatal Fc receptor (FcRn) in a pH-dependent manner, a process that protects the antibody from lysosomal degradation and extends its half-life in circulation to approximately three weeks (Roopenian DC, et al. Nat Rev Immunol. 2007). In biotechnology, the IgG1 Fc region is frequently engineered to modulate these effector functions or to create Fc-fusion proteins that benefit from its stability. In the context of autoimmune diseases, the IgG1 Fc-FcRn pathway is targeted by novel therapeutics like efgartigimod to accelerate the clearance of pathogenic autoantibodies (Gable K, et al. Neurotherapeutics. 2022).

Other names
Fc fragment of IgG1Fragment crystallizable region of IgG1IgG1 Fc domainImmunoglobulin G1 Fc
02

Mechanism of action

Modulation of Fc-mediated effector functions and competitive inhibition of the neonatal Fc receptor (FcRn) to regulate IgG1 serum concentrations.

03

Biological functions

Immune responseAntibody-dependent cellular cytotoxicityComplement-dependent cytotoxicitySerum half-life regulationAntibody-dependent cellular phagocytosis
04

Disease associations

Autoimmune diseaseCancerInfectionInflammation
05

Safety considerations

HypogammaglobulinemiaIncreased risk of infectionImmunogenicityInfusion-related reactions
06

Interacting drugs

Efgartigimod alfa

3 more in the full profile.

07

Biomarkers

Serum IgG1 levelsTotal serum IgG levelsFcγRIIIa (CD16a) polymorphismAnti-drug antibodies (ADA)

Beyond the preview

Go deeper on Immunoglobulin gamma 1 Fc region (IgG1 Fc) (IgG1 Fc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin gamma 1 Fc region (IgG1 Fc) (IgG1 Fc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call